1. Clinical Overview
A triple-drug, single-pill combination (SPC) antihypertensive therapy containing an angiotensin II receptor blocker (ARB), a dihydropyridine calcium channel blocker (CCB), and a thiazide-like diuretic. This SPC is designed for the effective management of essential hypertension, particularly in patients requiring more than two drugs to achieve blood pressure control, as per Indian and international guidelines. It offers complementary mechanisms, synergistic efficacy, improved compliance, and a favorable side effect profile by using lower doses of individual components.
| Onset | Duration | Bioavailability |
|---|---|---|
| Telmisartan: 1-2 hours; Amlodipine: 6-12 hours; Chlorthalidone: 2-6 hours. Significant antihypertensive effect is typically observed within 1-2 weeks of starting therapy. | Telmisartan: >24 hours; Amlodipine: 24-48 hours; Chlorthalidone: 24-72 hours. The combination provides sustained 24-hour blood pressure control with once-daily dosing. | Telmisartan: 42-58%; Amlodipine: 64-90%; Chlorthalidone: ~65%. |
2. Mechanism of Action
This combination exerts a multi-pronged attack on hypertension: 1) Telmisartan selectively blocks the binding of angiotensin II to the AT1 receptor, inhibiting vasoconstriction, aldosterone secretion, and sympathetic outflow. 2) Amlodipine inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle, causing peripheral arterial vasodilation and reduced peripheral vascular resistance. 3) Chlorthalidone inhibits sodium reabsorption in the distal convoluted tubule of the nephron, promoting natriuresis, diuresis, and a reduction in plasma volume. The combination results in synergistic vasodilation and volume reduction.
3. Indications & Uses
- Treatment of essential hypertension (Stage 2 or 3) in patients whose blood pressure is not adequately controlled on any two of the following: an ARB, a CCB, or a thiazide diuretic.
4. Dosage & Administration
Adult Dosage: One tablet (Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 6.25mg) orally once daily, with or without food. Dose may be titrated after 2-4 weeks based on response and tolerability. Maximum: One tablet daily.
Administration: Swallow the tablet whole with a glass of water, preferably at the same time each day (morning is common to avoid nocturia). Can be taken with or without food. Do not crush or chew. If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose.
5. Side Effects
Common side effects may include:
- Dizziness
- Headache
- Peripheral edema (ankle swelling) - primarily due to amlodipine
- Fatigue
- Flushing
- Nausea
- Increased urination (early in therapy)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Antihypertensives (Diuretics, Beta-blockers, ACEi) | Additive hypotensive effect; risk of severe hypotension. | Major |
| Potassium supplements, Potassium-sparing diuretics (Spironolactone, Amiloride), Salt substitutes | Increased risk of hyperkalemia due to telmisartan. | Major |
| NSAIDs (e.g., Ibuprofen, Diclofenac) | May reduce antihypertensive effect, increase risk of renal impairment and hyperkalemia. | Major |
| Lithium | Chlorthalidone reduces renal clearance of lithium, increasing risk of lithium toxicity. | Major |
| Digoxin | Chlorthalidone-induced hypokalemia may potentiate digoxin toxicity. | Moderate |
| Corticosteroids, ACTH | Intensify electrolyte depletion (hypokalemia). | Moderate |
| Cholestyramine, Colestipol | May reduce absorption of chlorthalidone. | Moderate |
| Strong CYP3A4 inhibitors (e.g., Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) | May increase amlodipine levels, increasing risk of hypotension and edema. | Moderate |
| Simvastatin | Amlodipine may increase simvastatin levels, slightly increasing risk of myopathy. | Minor |
| Alcohol | Potentiates orthostatic hypotension. | Moderate |
7. Patient Counselling
- DO take the tablet at the same time every day for consistent effect.
- DO continue taking this medicine even if you feel well. Hypertension often has no symptoms.
- DO get your blood pressure, kidney function, and electrolyte levels checked regularly as advised by your doctor.
- DO inform all your doctors and dentists that you are taking this medicine before any surgery or new prescription.
- DONT stop taking this medicine suddenly without consulting your doctor, as your blood pressure may rise rapidly.
- DONT take over-the-counter NSAIDs (like ibuprofen) for pain or fever without consulting your doctor.
- DONT use potassium supplements or salt substitutes containing potassium unless prescribed.
8. Toxicology & Storage
Overdose: Primary manifestation is profound hypotension, which may lead to shock, bradycardia/tachycardia, and electrolyte disturbances (hypokalemia or hyperkalemia, hyponatremia). Other symptoms include dizziness, tachycardia or reflex bradycardia, and acute renal failure due to hypoperfusion.
Storage: Store below 30°C. Protect from light and moisture. Keep the tablet in the blister pack until use. Keep out of reach of children.